The American Society of Clinical Oncology conducted an updated systematic review of the literature to provide guidance to clinicians regarding the use of systemic therapy for melanoma.
This recent research aims to construct a model based on necroptosis-related long non-coding RNAs for the prognosis of patients with melanoma. The study concludes that this prognostic model can independently predict the survival of melanoma patients while providing a basis for the subsequent investigation of necroptosis in melanoma and a new perspective on the clinical diagnosis and treatment of melanoma.
Previous research studies are typically siloed into the separate areas of vitamin D or skin cancer research. This recent study incorporated both topics and pooled the views of participants in two citizens' juries who agreed on the need for improved information about the harms and benefits of sun exposure to reflect a modern Australian population.
According to this recent study, post-treatment cancer survivorship should be established as a distinct phase of cancer care. Measures could include greater leadership in the survivorship space, the implementation of a survivorship model(s) of care and the use of survivorship care plans.
This study aimed to investigate the supportive care needs of Australian melanoma patients and their caregivers to form the basis for improving services. It found that Australian melanoma patients and caregivers frequently report unmet supportive care needs, particularly regarding their psychological and emotional well-being, and suggests psychological and emotional well-being services, such as access to a clinical psychologist or implementation of patient-reported outcome measures, should be incorporated into routine melanoma care.
This recent study demonstrates how in silico drug target prediction based on metabolic modelling can be a useful complement in the selection of tailored treatments to improve the therapeutic outcome of melanoma patients especially for those that relapse or do not respond to current melanoma treatments.
This recent longitudinal study investigated patterns of sun protective behaviours in Western Australian adolescents and adults over a six-year period.
This recent study investigated the impact of time of adjuvant immunotherapy on survival in patients with stage III melanoma.
This recent study attempted to validate the Melanoma Institute of Australia's Sentinel Node Metastasis Risk Prediction Tool using the National Cancer Database.
This recent study sought to determine whether histologic margin status is an independent predictor of progression for lentigo maligna melanomas.